Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 37% ± 22% | |
| oligodendrocyte precursor cell | 10 studies | 33% ± 14% | |
| astrocyte | 9 studies | 23% ± 6% | |
| interneuron | 6 studies | 30% ± 20% | |
| GABAergic neuron | 5 studies | 29% ± 6% | |
| neuron | 4 studies | 28% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 29% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 4148.81 | 651 / 653 | 85% | 49.55 | 513 / 605 |
| brain | 92% | 748.41 | 2425 / 2642 | 91% | 16.91 | 641 / 705 |
| blood vessel | 99% | 4955.36 | 1322 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 69% | 415.46 | 998 / 1445 | 22% | 2.17 | 40 / 183 |
| breast | 17% | 64.11 | 77 / 459 | 72% | 5.90 | 803 / 1118 |
| uterus | 62% | 342.81 | 105 / 170 | 23% | 2.31 | 104 / 459 |
| ovary | 23% | 123.39 | 42 / 180 | 44% | 3.39 | 190 / 430 |
| liver | 47% | 177.62 | 107 / 226 | 9% | 0.55 | 38 / 406 |
| intestine | 38% | 171.06 | 365 / 966 | 18% | 1.08 | 93 / 527 |
| pancreas | 1% | 1.56 | 2 / 328 | 39% | 1.74 | 69 / 178 |
| lung | 18% | 83.87 | 103 / 578 | 21% | 1.35 | 237 / 1155 |
| stomach | 18% | 53.82 | 64 / 359 | 20% | 1.38 | 58 / 286 |
| bladder | 14% | 85.00 | 3 / 21 | 19% | 1.18 | 95 / 504 |
| kidney | 4% | 18.01 | 4 / 89 | 23% | 1.20 | 208 / 901 |
| prostate | 14% | 42.74 | 34 / 245 | 10% | 0.47 | 52 / 502 |
| tonsil | 0% | 0 | 0 / 0 | 22% | 1.91 | 10 / 45 |
| adipose | 17% | 75.27 | 205 / 1204 | 0% | 0 | 0 / 0 |
| skin | 11% | 35.91 | 206 / 1809 | 5% | 0.48 | 22 / 472 |
| heart | 8% | 27.01 | 65 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 3.00 | 2 / 258 | 1% | 0.03 | 3 / 230 |
| muscle | 0% | 0.32 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0097503 | Biological process | sialylation |
| GO_0009311 | Biological process | oligosaccharide metabolic process |
| GO_0006486 | Biological process | protein glycosylation |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0032580 | Cellular component | Golgi cisterna membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0003835 | Molecular function | beta-galactoside alpha-2,6-sialyltransferase activity |
| Gene name | ST6GAL2 |
| Protein name | ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 (EC 1.4.99.1, EC 2.4.99.1) Beta-galactoside alpha-2,6-sialyltransferase 2 (Alpha 2,6-ST 2) (EC 2.4.3.1) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 2) (ST6Gal II) (ST6GalII) (hST6Gal II) (Sialyltransferase 2) ST6 beta-galactoside alpha-2,6-sialyltransferase 2 |
| Synonyms | KIAA1877 SIAT2 |
| Description | FUNCTION: Transfers sialic acid from the donor of substrate CMP-sialic acid to galactose containing acceptor substrates. Has alpha-2,6-sialyltransferase activity toward oligosaccharides that have the Gal-beta-1,4-GlcNAc sequence at the non-reducing end of their carbohydrate groups, but it has weak or no activities toward glycoproteins and glycolipids. . |
| Accessions | ENST00000361686.8 [Q96JF0-1] C4N9P8 C9JIK2 ENST00000409382.8 [Q96JF0-1] ENST00000419159.2 H7BY52 ENST00000409087.3 [Q96JF0-2] Q96JF0 ENST00000361803.3 |
